JWN
48
-2
FAST
57
-3
MAS
52
-4
AON
54
2
ADP
65
-3
PLD
45
-5
ORLY
60
-5
HIG
66
2
FRT
41
-2
LRCX
37
-9
SLG
57
-3
GRMN
67
-4
URBN
48
-6
SPG
60
2
ILMN
32
-9
BSX
64
-3
TRIP
50
-4
SCHW
62
-2
GM
74
5
K
51
-3
JWN
48
-2
FAST
57
-3
MAS
52
-4
AON
54
2
ADP
65
-3
PLD
45
-5
ORLY
60
-5
HIG
66
2
FRT
41
-2
LRCX
37
-9
SLG
57
-3
GRMN
67
-4
URBN
48
-6
SPG
60
2
ILMN
32
-9
BSX
64
-3
TRIP
50
-4
SCHW
62
-2
GM
74
5
K
51
-3
Financhill
Back

Essent Group Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
38

ESNT
Essent Group

Last Price:
55.50
Seasonality Move:
2.2%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
38
Essent Group (ESNT) is a Sell

Is Essent Group a Buy, Sell or Hold?

  • The current Essent Group [ESNT] share price is $55.50. The Score for ESNT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • ESNT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ESNT Stock Price Chart

What is Essent Group's stock price today?

  • The Essent Group share price today is $55.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ESNT is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

ESNT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.78 Sell
Relative Strength Index (14 RSI): 36.37 Sell
Chaikin Money Flow: -848592 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.61 - 62.79) Sell
Bollinger Bands (100): (57.61 - 63.79) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

ESNT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.01 Sell
20-day SMA: 58.05 Sell
50-day SMA: 61.3 Sell
200-day SMA: 57.93 Sell
8-day EMA: 56.17 Sell
20-day EMA: 57.78 Sell
50-day EMA: 59.81 Sell
200-day EMA: 57.84 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Essent Group Earnings Growth & ESNT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.08 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Essent Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):